Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Invested Capital: 2020-2025

Historic Invested Capital for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $3.1 million.

  • iSpecimen's Invested Capital fell 34.83% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 34.83%. This contributed to the annual value of $3.3 million for FY2024, which is 66.01% down from last year.
  • As of Q3 2025, iSpecimen's Invested Capital stood at $3.1 million, which was up 394.03% from $621,973 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Invested Capital peaked at $29.8 million during Q4 2021, and registered a low of $621,973 during Q2 2025.
  • Over the past 3 years, iSpecimen's median Invested Capital value was $6.1 million (recorded in 2024), while the average stood at $7.4 million.
  • Per our database at Business Quant, iSpecimen's Invested Capital soared by 231.31% in 2021 and then crashed by 89.79% in 2025.
  • iSpecimen's Invested Capital (Quarterly) stood at $29.8 million in 2021, then tumbled by 31.83% to $20.3 million in 2022, then crashed by 52.04% to $9.7 million in 2023, then slumped by 66.01% to $3.3 million in 2024, then tumbled by 34.83% to $3.1 million in 2025.
  • Its Invested Capital was $3.1 million in Q3 2025, compared to $621,973 in Q2 2025 and $1.7 million in Q1 2025.